BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Eosinophilic Granulomatosis with Polyangiitis readouts · Asse
 tMemo
X-WR-CALDESC:Upcoming phase 1/2 and later readouts in Eosinophilic Granulom
 atosis with Polyangiitis\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05979051-11077@assetmemo.bio
DTSTAMP:20261122T012611Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:SHR-1703: Phase 2/3 readout est. (NCT05979051)
DESCRIPTION:SHR-1703\, phase 2/3\, Eosinophilic Granulomatosis with Polyang
 iitis.\nStudy: A Study to Evaluate the Efficacy and Safety of SHR-1703 in 
 Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）\nEs
 timated primary completion: December 2028. This is a ClinicalTrials.gov es
 timate\, not a confirmed readout date\, and it can move.\nDrug page: https
 ://assetmemo.bio/drug/shr-1703#upcoming-events\nRegistry record: https://c
 linicaltrials.gov/study/NCT05979051
URL:https://assetmemo.bio/drug/shr-1703#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
